Molecular Insights in to the Gastro protective Potential of Marmin and Imperator in: A Phytochemical and Mechanistic Perspective

Abstract

Peptic ulceration of the stomach continues to represent a common digestive system pathology distinguished by epithelial injury arising from disequilibrium between harmful elements including gastric acidity, reactive oxygen species, and inflammatory processes, and the protective systems of the gastric lining. Although established treatment modalities exist, encompassing proton pump inhibitors and H₂-receptor antagonists, prolonged administration frequently correlates with undesirable consequences and disease recurrence, creating demand for investigating more secure and efficacious therapeutic options. Within this framework, naturally derived coumarins have attracted substantial interest owing to their varied pharmacological attributes. Marmin and imperatorin, two notable furanocoumarins obtained from therapeutic plants including Aegle marmelos and Angelica species, demonstrate considerable gastric protective capabilities. This analysis thoroughly examines the phytochemical features, pharmacokinetic characteristics, and fundamental action mechanisms of marmin and imperatorin in gastric ulcer prevention and treatment. Data from laboratory and animal investigations indicate that these substances provide protective benefits via numerous mechanisms, encompassing antioxidant function, suppression of inflammatory factors, strengthening of mucosal protection, and regulation of gastric acid production. Furthermore, their possible anti-Helicobacter pylori properties additionally validate their clinical significance. The analysis emphasizes existing constraints, safety aspects, and developing formulation approaches designed to enhance bioavailability. In summary, marmin and imperatorin constitute encouraging prospects for developing innovative gastroprotective compounds. Additional clinical research is required to confirm their effectiveness and safety in human subjects and to enable their progression toward therapeutic implementation.